1.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: URO-OBT-01, NCT01446822
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 to 89 Sponsor: Other Protocol IDs: PK Button and Bladder Tumors, NCT01567462
|
|
3.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CDR0000640393, OCTG-LaMB, BL-2007-02, EUDRACT-2007-001826-28, EU-20929, NCT00949455
|
|
4.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 12154, NCT01438112
|
|
5.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A9EO9201, EO9_C301, NCT01475266
|
|
6.
|
Phase: Phase III, Phase II Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: RRK4368, 2012-002552-16, NCT01668459
|
|
7.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: B9E-MC-S062, AB 22/00, NCT00146276
|
|
8.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2003/081/HP, NCT00213655
|
|
9.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VRAM M-20070240, NCT00647569
|
|
10.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Pharmaceutical / Industry Protocol IDs: 102.1, NCT00384891
|
|
11.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000602239, UZG-CUL-UHG-Non-InvasiveBladde, EU-20870, UZG-CUL-UHG-Non-InvasiveBladderCancer, CUL-UHG-Non-Invasive Bladder Cancer, NCT00729287
|
|
12.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 25387, 1 R01 HL95109-01, NCT00876915
|
|
13.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CALGB-90601, CALGB-90601, NCT00942331
|
|
14.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 10-016, NCT01076387
|
|
15.
|
Phase: Phase III Type: Health services research, Supportive care Status: Active Age: Over 18 Sponsor: Other Protocol IDs: CDR0000667367, RMH-CCR3086, EUDRACT-2008-002152-26, EU-21010, MREC-08/H0903/40, NCT01087268
|
|
16.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: EMBARK, NCT01082510
|
|
17.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Health services research, Treatment Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CRC-TU-BL3010-HYMN, CRCTU-BL3010-HYMN, ISRCTN85785327, EUDRACT-2008-005428-99, EU-21015, UCL-08/0365, KYOWA-CRC-TU-BL3010-HYMN, MREC-09/H0717/56, NCT01094964
|
|
18.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EN3348-303, NCT01200992
|
|
19.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S1011, S1011, NCT01224665
|
|
20.
|
Phase: Phase III Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
|
|
21.
|
Phase: Phase III Type: Supportive care Status: Approved-not yet active Age: 20 to 80 Sponsor: Other Protocol IDs: CMC-11-0015-CTIL, NCT01542567
|
|
22.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CUHK_TURB_2012, NCT01581723
|
|
23.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: FinnBladder 9, 2012-000559-15, NCT01675219
|
|
24.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0524, NCT00238420
|
|
25.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000492014, U01CA062505, CCC-PHII-75, NCI-7435, 7435, NCT00365157
|